Vaccine News and Research

RSS

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

Study Provides Insight into the Formation of Protective Memory T Cells Against Salmonella

Salmonella infections cause about a million deaths a year worldwide, and there is an urgent need for better vaccines for both typhoid fever and non-typhoidal Salmonella disease.

18 Apr 2023

A Nanoplasmonics Approach to Observe Real-Time Production of Cell Secretions

Researchers at the University of Geneva have developed a novel optical imaging approach that provides a four-dimensional view of cell secretions in real-time, including their spatial and temporal dynamics.

13 Apr 2023

Organoid Platform Could Help Reduce the Time for Developing New Conjugate Vaccines

Developing and testing new treatments or vaccines for humans almost always requires animal trials, but these experiments can sometimes take years to complete and can raise ethical concerns about the animals' treatment.

13 Apr 2023

New Method for Improving Gene Therapy With Nanobubbles

Beyond vaccines, mRNA offers immense potential to fight disease, but targeting the genetic material to specific diseased cells is challenging-; requiring a new method.

12 Apr 2023

Research Reveals Why Viruses can Reinfect a Population of Previously Immune Hosts

The human body is capable of creating a vast, diverse repertoire of antibodies-;the Y-shaped sniffer dogs of the immune system that can find and flag foreign invaders.

7 Apr 2023

Study Paves the Way to Targeted Treatments for Stargardt Disease

A recent study in the Journal of Biological Chemistry revealed the key to a protein that commonly causes blindness.

5 Apr 2023

Jumping Genes in Various Cancers may be Used to Direct Novel Immunotherapies to Tumors

New research from Washington University School of Medicine in St. Louis suggests that transposable elements in various cancers potentially may be used to harness novel immunotherapies against tumors that don't typically respond to immune-based treatments. Shown is a 3D rendering of cancer cells.

4 Apr 2023

Two types of immune cells interact to give natural protection from tuberculosis

A new study has uncovered the role of B and T cells in controlling tuberculosis (TB) infections.

3 Apr 2023

Single monoclonal antibody infusion can strengthen the body's fight against yellow fever

New research from Oregon Health & Science University and collaborators indicates lab-made antibodies may be able to cure people infected with yellow fever, a virus for which there is no treatment.

30 Mar 2023

COVID-19 vaccines boost the levels of T cells in immunocompromised hematology patients

Researchers found that, despite being heavily immunocompromised, hematology patients generate strong cellular immune responses against SARS-CoV-2 after vaccination, on par with that of healthy individuals.

30 Mar 2023

Novel inhibitor, hopeaphenol, blocks HIV expression

In the United States, around 1.2 million people are living with HIV as of 2022. Many of these people can now live productive, symptom-free lives thanks to antiretroviral therapies, but a solution that permanently removes HIV from an infected person’s body is still a long way off.

30 Mar 2023

No more needles? Future vaccines could be delivered by a puff of air

In the future, vaccines may be delivered with a puff of air rather than a needle, according to the promising results of new research presented at a meeting of the American Chemistry Society this March.

27 Mar 2023

Common Epstein-Barr virus may be a trigger for multiple sclerosis

In 1868, French physician Jean-Martin Charcot, known as the founder of modern neurology, defined a disease entity in which multiple plaques formed in the brain and spinal cord, with varying physical symptoms, called Sclérose en plaques, or in English as multiple sclerosis (MS).

24 Mar 2023

Study examines the implications of vaccine shopping during pandemic

When COVID-19 vaccines became obtainable in the United States, the policy of the Centers for Disease Control and Prevention was that individuals should receive the first available vaccine.

23 Mar 2023

Identifying the underlying causes of rare genetic immune disorders

The activated PI3K Delta syndrome 2 (APDS2) is a rare genetic disease that is caused by cellular anomalies, according to experts from the Garvan Institute of Medical Research.

23 Mar 2023

Novel tool analyzes how immune cells respond to SARS-CoV-2 vaccination

A study discovered that the magnitude and quality of a key immune cell’s response to two doses of the Pfizer-BioNTech COVID-19 vaccine were significantly lower in individuals with earlier SARS-CoV-2 infection compared to individuals without previous infection.

21 Mar 2023

New antibody "cocktail" may help counter the Lassa virus

The finding, made with the use of the Advanced Photon Source, shows a new way to exploit monoclonal antibodies to subvert the "shield" of the virus, potentially paving the way for new therapies.

20 Mar 2023

Study reveals: Coronaviruses that cause common colds boost immune response to COVID-19

During the pandemic, it became clear that children who contracted COVID-19 became less ill than adults. One hypothesis has been that common colds would give children immunity protecting against a severe form of the disease. Researchers at Karolinska Institutet are now able to show that OC43, one of the coronaviruses that cause common colds, boosts the immune response to COVID-19. The study, which is published in PNAS, could give rise to more tailored vaccine programmes for children and adults.

16 Mar 2023

Novel web-based tool deoptimizes genetic sequences based on different codon usage

A new software tool developed by Texas Biomedical Research Institute and collaborators can help scientists and vaccine developers quickly edit genetic blueprints of pathogens to make them less harmful.

16 Mar 2023

New perspective on how immune cells perceive viruses and other threats

A textbook chapter on the immune system may need to be revised as a result of a new study from Aarhus University.

14 Mar 2023

Vaccine News and Research

Further Reading

Study Provides Insight into the Formation of Protective Memory T Cells Against Salmonella

A Nanoplasmonics Approach to Observe Real-Time Production of Cell Secretions

Organoid Platform Could Help Reduce the Time for Developing New Conjugate Vaccines

New Method for Improving Gene Therapy With Nanobubbles

Research Reveals Why Viruses can Reinfect a Population of Previously Immune Hosts

Study Paves the Way to Targeted Treatments for Stargardt Disease

Jumping Genes in Various Cancers may be Used to Direct Novel Immunotherapies to Tumors

Two types of immune cells interact to give natural protection from tuberculosis

Single monoclonal antibody infusion can strengthen the body's fight against yellow fever

COVID-19 vaccines boost the levels of T cells in immunocompromised hematology patients

Novel inhibitor, hopeaphenol, blocks HIV expression

No more needles? Future vaccines could be delivered by a puff of air

Common Epstein-Barr virus may be a trigger for multiple sclerosis

Study examines the implications of vaccine shopping during pandemic

Identifying the underlying causes of rare genetic immune disorders

Novel tool analyzes how immune cells respond to SARS-CoV-2 vaccination

New antibody "cocktail" may help counter the Lassa virus

Study reveals: Coronaviruses that cause common colds boost immune response to COVID-19

Novel web-based tool deoptimizes genetic sequences based on different codon usage

New perspective on how immune cells perceive viruses and other threats

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics